GT Biopharma Inc. (NASDAQ: GTBP)
$2.82
+0.0200 ( +0.71% ) 8.4K
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
Market Data
Open
$2.82
Previous close
$2.80
Volume
8.4K
Market cap
$6.08M
Day range
$2.77 - $2.89
52 week range
$2.60 - $10.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Jun 27, 2024 |
8-k | 8K-related | 13 | Jun 26, 2024 |
3 | Insider transactions | 1 | Jun 13, 2024 |
8-k | 8K-related | 14 | Jun 07, 2024 |
8-k | 8K-related | 20 | May 23, 2024 |
10-q | Quarterly Reports | 68 | May 15, 2024 |
8-k | 8K-related | 15 | Apr 30, 2024 |
def | Proxies and info statements | 3 | Apr 29, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
10-k | Annual reports | 89 | Mar 26, 2024 |